Dr. Reddy's and Nestle India to form JV for health science nutraceutical portfolio
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Sales reflect continued strong growth in oncology and vaccines
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Around 7% of the Indian population suffers from IBS
Submission based on results from pivotal phase III trial showing all primary endpoints met
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Subscribe To Our Newsletter & Stay Updated